Latest filing published 17 Apr 2025 for Immunovant, Inc., €39k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Eva Renee Barnett: trading record in brief
Eva Renee Barnett (finance chief) discloses dealings in Immunovant, Inc. to SEC (Form 4). Between 4 October 2021 and 16 April 2025, the trades on record add up to 39 filings.
No open-market purchase appears, only 33 sales worth €2.8M. Outside the open market, there are 6 share grants. Since January 2025: no purchases and 7 sales on the market.
The record was last updated on 17 April 2025 with an open-market sale (€39k) in Immunovant, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Eva Renee Barnett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,993 shares@ US$14.891.4% of flowCommon StockSEC:0001764013-25-000076:0
- 7,013 shares@ US$12.993.0% of flowCommon StockSEC:0001764013-25-000067:0
- 88,878 shares0Common StockSEC:0001764013-25-000051:0
- 2,814 shares@ US$20.862.0% of flowCommon StockSEC:0001764013-25-000031:0
- 2,189 shares@ US$23.811.8% of flowCommon StockSEC:0001764013-25-000014:0
- 4,105 shares@ US$24.103.4% of flowCommon StockSEC:0001764013-25-000004:0
- 4,174 shares@ US$25.453.6% of flowCommon StockSEC:0001764013-24-000194:0
- 3,271 shares@ US$28.793.1% of flowCommon StockSEC:0001764013-24-000171:0
- 5,162 shares@ US$29.565.0% of flowCommon StockSEC:0001764013-24-000166:0
- 3,619 shares@ US$31.843.7% of flowCommon StockSEC:0001764013-24-000158:0
- 2,939 shares@ US$29.642.9% of flowCommon StockSEC:0001764013-24-000135:0
- 4,747 shares@ US$28.064.4% of flowCommon StockSEC:0001764013-24-000127:0
- 4,042 shares@ US$29.654.0% of flowCommon StockSEC:0001764013-24-000099:0
- 9,479 shares@ US$28.809.2% of flowCommon StockSEC:0001764013-24-000079:0
- 3,689 shares@ US$31.183.8% of flowCommon StockSEC:0001764013-24-000073:0
- 54,978 shares0Common StockSEC:0001764013-24-000046:0
- 2,930 shares@ US$36.153.5% of flowCommon StockSEC:0001764013-24-000041:0
- 2,681 shares@ US$41.643.6% of flowCommon StockSEC:0001764013-24-000010:0
- 3,901 shares@ US$32.754.2% of flowCommon StockSEC:0001764013-23-000144:0
- 4,557 shares@ US$36.925.7% of flowCommon StockSEC:0001764013-23-000120:0
- 14,385 shares@ US$20.309.7% of flowCommon StockSEC:0001764013-23-000103:0
- 2,725 shares@ US$24.942.2% of flowCommon StockSEC:0001764013-23-000080:0
- 3,423 shares@ US$15.271.7% of flowCommon StockSEC:0001764013-23-000053:0
- 87,664 shares0Common StockSEC:0001764013-23-000040:0
- 11 shares@ US$15.150.0% of flowCommon StockSEC:0001764013-23-000008:0
25 of 30 declarations
